Press Releases

WARREN, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes (“CD8+ CTLs”), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders with the aim of addressing the significant unmet... (continue reading...)

The Company Strengthens Balance Sheet, Takes Strides to Regaining Nasdaq Listing Compliance

DENVER, CO / ACCESSWIRE / June 6, 2024 / SOBR Safe, Inc. (NASDAQ: SOBR) ("SOBRsafe" or "the Company"), provider of next-generation transdermal alcohol detection solutions, announced today that it has received approximately $2.8 million in gross proceeds from the exercise of Warrants. Details on the transaction are below, or view the corresponding Form 8-K.

SOBRsafe has also... (continue reading...)

SÃO PAULO, June 6, 2024 /PRNewswire/ -- ITAÚ UNIBANCO HOLDING S.A. informs its stockholders that its Board of Directors has approved, at the meeting held on this date, the payment of interest on capital to stockholders ("IOC") in the amount of R$0.2510 per share, with income tax withholding at a rate of 15%, resulting in net interest of R$0.21335 per share, except for the corporate stockholders able to prove that they are immune or exempt from such withholding. The... (continue reading...)

Calgary, Alberta--(Newsfile Corp. - June 6, 2024) - Suncor (TSX: SU) (NYSE: SU) President and Chief Executive Officer Rich Kruger says Canada can increase its prosperity for the benefit of all Canadians while also mitigating the impacts of climate change if government and industry work together.

Kruger appeared today before the House of Commons Standing Committee on Environment and Sustainable Development as part of a panel of executives from Canada's largest energy... (continue reading...)

LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Marinus Pharmaceuticals, Inc. (“Marinus” or “the Company”) (NASDAQ: MRNS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities... (continue reading...)